XML 101 R86.htm IDEA: XBRL DOCUMENT v3.22.0.1
Capital Stock, Stock Awards, and Stock Options (Narrative) (Details) - USD ($)
1 Months Ended 12 Months Ended
Jan. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Sep. 10, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Cost of shares repurchased by company   $ 55,683,000 $ 161,829,000 $ 2,103,000  
Shares subject to award outstanding   31,571 27,240    
Number of shares forfeited due to modification   3,056      
Number of shares awarded in 2021   20,258      
Exercised, Number of Shares   0      
Number of shares granted   0      
Stock options outstanding   183,189 183,189    
Dividends declared per common share   $ 6.04 $ 5.80 $ 5.56  
Kaplan Stock Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Exercised, Number of Shares   0 0 0  
Number of shares granted   0 0 0  
Stock options outstanding   0      
Share-based Payment Arrangement, Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares excluded from earnings per share   104,000 181,258 104,000  
Maximum [Member] | Kaplan Stock Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period   5 years      
Minimum [Member] | Kaplan Stock Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period   4 years      
Education [Member] | Kaplan Stock Option and Restricted Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense (credit)   $ 1,300,000 $ (1,100,000) $ (1,300,000)  
Accrual balance related to stock based compensation   10,300,000      
Stock compensation payouts   $ 0 $ 0 $ 0  
Class B Common Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Right to elect Board of Directors percentage   30.00%      
Shares repurchased by company   93,969 406,112 3,392  
Cost of shares repurchased by company   $ 55,700,000 $ 161,800,000 $ 2,100,000  
Number of shares authorized to be repurchased         500,000
Authorized shares remaining for repurchase   270,182      
Market value of company's stock (in dollars per share)   $ 629.83      
Class B Common Stock [Member] | Restricted Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share awards outstanding, restriction will lapse in 2023   12,820      
Share awards outstanding, restriction will lapse in 2025   16,751      
Share awards outstanding, restriction will lapse in 2027   2,000      
Stock-based compensation expense (credit)   $ 3,900,000 4,100,000 4,200,000  
Total unrecognized compensation expense   $ 9,800,000      
Years over which cost expected to be recognized   2 years 3 months 18 days      
Class B Common Stock [Member] | Share-based Payment Arrangement, Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based compensation expense (credit)   $ 1,700,000 $ 2,200,000 $ 2,000,000  
Total unrecognized compensation expense   $ 5,700,000      
Years over which cost expected to be recognized   4 years 8 months 12 days      
Options outstanding exercisable now   118,139      
Options outstanding exercisable in 2022 (shares)   13,209      
Options outstanding exercisable in 2023 (shares)   13,211      
Options outstanding exercisable in 2024 (shares)   12,876      
Options outstanding exercisable in 2025 (shares)   12,877      
Options outstanding exercisable in 2026 (shares)   12,877      
Intrinsic value of options outstanding   $ 16,400,000      
Intrinsic value of options exercisable   3,400,000      
Intrinsic value of options unvested   $ 13,100,000      
Options unvested, shares   65,050 82,385    
Options unvested, average exercise price (in dollars per share)   $ 431.16 $ 453.97    
Options unvested, weighted average remaining contractual term, years   8 years 8 months 12 days 9 years 4 months 24 days    
Exercised, Number of Shares   0 77,258 1,743  
Intrinsic value of options exercised     $ 11,100,000 $ 600,000  
Tax benefit from stock option exercises     $ 2,900,000 $ 200,000  
Class B Common Stock [Member] | 2012 Incentive Compensation Plan [Member] | Share-based Payment Arrangement [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares reserved for stock awards granted under the plan   772,588      
Shares reserved for issuance   545,000      
Shares subject to award outstanding   214,760      
Shares available for future awards   330,240      
Class B Common Stock [Member] | 2012 Incentive Compensation Plan [Member] | Maximum [Member] | Share-based Payment Arrangement, Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period   10 years      
Class B Common Stock [Member] | 2012 Incentive Compensation Plan [Member] | Minimum [Member] | Share-based Payment Arrangement, Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period   6 years      
Kaplan Restricted Stock [Member] | Senior Manager [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares subject to award outstanding   7,206      
Kaplan Restricted Stock [Member] | Subsequent Event [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Fair value of company common stock (in dollars per share) $ 1,425        
Exercise Price Above Fair Market Value Of Common Stock [Member] | Class B Common Stock [Member] | Share-based Payment Arrangement, Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares granted   0 77,258 0  
Weighted average fair value, granted options (in dollars per share)     $ 93.79